Trade 78

BUY XLV

3.228931223 shares at $154.85 on 2026-06-09

Reasoning

Execute playbook action #125. Formation-mode entry into XLV as the cleanest diversified expression of the durable defensive rotation (thesis #58). Healthcare is the #1 sector over 5d (+5.8%) and green today while tech de-rates sharply (SOXL ~-15%, tech -2.5% 1d). Per Rule #26, rate-shielded defensives are the correct ballast in this real-yield-repricing regime. XLV provides diversified exposure vs. single-name risk (e.g., LLY's June 3 investment-halving overhang). macro_signal:sector shows strong recent attribution (STRONG, +1.92% avg 7d alpha per playbook) with confirmed multi-session leadership, meeting the multi-signal corroboration standard. Formation sizing ($500) per Rule #1/#4 (FOMC-window caution: June 18 FOMC decision ~9 days out, so cap new growth adds). This is a complementary defensive rotation, not a growth add, so it clears rate-regime constraints.

Thesis

XLV healthcare ETF — wind-down COMPLETION (supervisor item 70: exit incomplete since June 19). The managed-exit decision stands even though healthcare is leading today's tape (+1.8% 1d): the defensive sleeve is already covered by higher-conviction single names (LLY, MRK) plus XLP ballast, making the ETF wrapper redundant, and the sleeve's own terms state full exit is acceptable on any session with adequate liquidity. Eight weeks of incomplete wind-down is a resolution failure, not a re-validation — finish the exit rather than flip-flop the lowest-conviction wrapper back to a hold on one strong session. (long, low confidence)

Outcome

7-day: -3.39% · 30-day: +4.25%

Cited evidence

Macro